Abstract
Autologous chondrocyte implantation (ACI) is a widely accepted procedure for the treatment of large, full-thickness chondral defects involving various joints, but its use in developing countries is limited because of high cost and failure rates due to limited resources and support systems. Five patients (age
Original language | English |
---|---|
Pages (from-to) | 8 - 13 |
Number of pages | 6 |
Journal | Journal of Health and Translational Medicine |
Volume | 17 |
Issue number | 1 |
Publication status | Published - 2014 |